Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+, Mozilla Firefox 20+, Internet Explorer 11, Opera 15–18, Apple Safari 7, SeaMonkey 2.15-2.23

Next generation immunotherapies in thoracic malignancies

Targeting T cells beyond PD-1/PD-L1 axis: Other checkpoints inhibitors and costimulatory receptors agonists

Date

14 Sep 2024

Session

Next generation immunotherapies in thoracic malignancies

Topics

Immunotherapy

Tumour Site

Thoracic Malignancies

Presenters

Nathalie Chaput-Gras

Authors

N. Chaput-Gras

Author affiliations

Hematology Department, Institut Gustave Roussy, 94805 - Villejuif, Cedex/FR

Resources

This content is available to ESMO members and event participants.

Resources from the same session

14 Sep 2024

Introduction and scientific background

Presenter: Lizza Hendriks

Session: Next generation immunotherapies in thoracic malignancies

Resources:

Webcast

14 Sep 2024

Immune-cell engagers

Presenter: Adrian Sacher

Session: Next generation immunotherapies in thoracic malignancies

Resources:

Slides

Webcast

14 Sep 2024

Vaccines

Presenter: Joachim Aerts

Session: Next generation immunotherapies in thoracic malignancies

Resources:

Slides

Webcast

14 Sep 2024

Cellular therapies

Presenter: Michal Lotem

Session: Next generation immunotherapies in thoracic malignancies

Resources:

Slides

Webcast

14 Sep 2024

Q&A and discussion

Session: Next generation immunotherapies in thoracic malignancies

Resources:

Webcast

14 Sep 2024

Conclusions and perspectives

Presenter: Nathalie Chaput-Gras

Session: Next generation immunotherapies in thoracic malignancies

Resources:

Slides

Webcast